Verastem Inc Sustainability Reports
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing small molecule drugs to treat cancer. Its clinical programs primarily focus on targeting signaling pathways to improve treatment options for RAS/MAPK-driven cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300IY0EFBIU8NQC81
FIGI: BBG001V0G978
2 reports from 2014 to 2016